HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.060
Day range
$0.056 - $0.056
Year range
$0.034 - $0.13
Market cap
9.65M USD
Avg Volume
19.97K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 674.55K | -12.94% |
Net income | -632.85K | 7.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.32M | -43.74% |
Total assets | 4.51M | -42.20% |
Total liabilities | 3.15M | -0.09% |
Total equity | 1.35M | — |
Shares outstanding | 172.32M | — |
Price to book | 6.00 | — |
Return on assets | -33.07% | — |
Return on capital | -98.57% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -632.85K | 7.57% |
Cash from operations | -1.28M | -10.96% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.28M | -10.96% |
Free cash flow | -1.07M | -12.13% |
About
Founded
1992
Headquarters
Website
Employees
6
